I am Reader in Psychiatry and Youth Mental Health at the Institute of Psychiatry, Psychology and Neuroscience at King’s College London, where I head the Early Psychosis: Intervention and Clinical-detection (EPIC) lab, which employs precision medicine and neuroscience methods in combination with experimental psychopharmacological treatments for the prevention of mental disorders.
I am honoured to be leading the Early Psychosis work stream of the newly-created NIHR Translational Research Collaboration (TRC) for Mental Health, with the hope of helping the many young people experiencing emerging serious mental disorders such as psychosis.
I have an outstanding expertise and track record of evidence-based medicine and evidence synthesis. I lead the largest and oldest clinical service for the prevention of psychosis in individuals at high clinical risk in Europe (OASIS). I am also leading the international European College of NeuroPsychopharmacology Thematic Working Group (TWG) for the Prevention of Mental Disorders and Mental Health Promotion (PMD-MHP).
I have authored about 300 publications in the international databases, with an h-index of 74. I am PI or Co-I on several grants that are implementing precision medicine approaches for the detection, prognosis and treatments of individuals at risk of developing psychosis or bipolar disorders, in partnership with international research consortia or with the industry (e.g. HARMONY, PSYSCAN). Since 2015, I have been listed by Thomson Reuters/Clarivate Analytics as one of the “most influential scientific minds” and in the top 1% of highly-cited scientists in psychiatry.